BostonGene Announces Publication in Collaboration with National Cancer Institute and National Institute of Allergy and Infectious Diseases in Cancer Cell

WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, today announced the publication of the manuscript, “Multi-omic Profiling of Follicular Lymphoma Reveals Changes in Tissue Architecture and Enhanced Stromal Remodeling in High-Risk Patients” in Cancer Cell, a premier peer-reviewed scientific journal that publishes high-impact results in cancer research and oncology. Follicular lymphoma (FL), an often incurable malignancy, stems